HEATHER POROPAT: Open Payments
NPI 1821742180 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,532 in 169 payments from 13 companies in 2025. Trend: 2023 $219 · 2024 $49 · 2025 $3,532
Food & beverage: $3,432Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $724 |
| Janssen Biotech, Inc. | 19 | $662 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $632 |
| PFIZER INC. | 24 | $408 |
| Lilly USA, LLC | 10 | $237 |
| Regeneron Healthcare Solutions, Inc. | 10 | $230 |
| GENZYME CORPORATION | 7 | $161 |
| Aimmune Therapeutics, Inc. | 6 | $116 |
| Madrigal Pharmaceuticals | 4 | $102 |
| Ardelyx, Inc. | 3 | $73 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, LINZESS, XELJANZ, RINVOQ, OMVOH, VELSIPITY.
Industry payments across MO — which companies pay providers there.
